title: A common medication for neuropsychiatric illnesses may cause common problems in pregnancy.
authors.affiliation: From Harvard Medical School (P.B.P.), Brigham and Women's Hospital, Boston, MA; and Stanford University School of Medicine (K.J.M.), Palo Alto, CA. ppennell@partners.org.
authors.forename: Page B
authors.initials: PB
authors.lastname: Pennell
authors.affiliation: From Harvard Medical School (P.B.P.), Brigham and Women's Hospital, Boston, MA; and Stanford University School of Medicine (K.J.M.), Palo Alto, CA.
authors.forename: Kimford J
authors.initials: KJ
authors.lastname: Meador
mesh_terms: D000014:Abnormalities, Drug-Induced / Q000453:epidemiology / Q000209:etiology*; D002121:Calcium Channel Blockers / Q000009:adverse effects*; D005260:Female; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy*; D010146:Pain / Q000188:drug therapy*; D000069583:Pregabalin / Q000009:adverse effects*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000139:chemically induced / Q000188:drug therapy / Q000453:epidemiology; D011256:Pregnancy Outcome / Q000453:epidemiology; D047928:Premature Birth / Q000139:chemically induced* / Q000453:epidemiology
chemical_list: D002121:Calcium Channel Blockers; D000069583:Pregabalin